{"id":"NCT00614445","sponsor":"Duchesnay Inc.","briefTitle":"The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy","officialTitle":"A Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Of The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-07","completion":"2009-12","firstPosted":"2008-02-13","resultsPosted":"2011-09-05","lastUpdate":"2021-11-23"},"enrollment":280,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Nausea and Vomiting of Pregnancy"],"interventions":[{"type":"DRUG","name":"doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg","otherNames":["Diclectin®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Diclectin®","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of pregnancy than a placebo.","primaryOutcome":{"measure":"Diclectin Versus Placebo for Treatment of Nausea and Vomiting of Pregnancy (NVP) as Measured by the Change in Pregnancy Unique-Quantification of Emesis (PUQE) Overall Score of Symptoms From Baseline (Day 1) to End of Study Visit (Day 15).","timeFrame":"Baseline (Day 1) to End of Study Visit Day 15 (± 1 day)","effectByArm":[{"arm":"Diclectin®","deltaMin":-4.8,"sd":null},{"arm":"Placebo","deltaMin":-3.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["29342163","27881103","26844757","25884778","25052410","22972538","20843504"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":133},"commonTop":["Headache","Somnolence","Fatigue","Dizziness","Adominal Pain"]}}